NCT06483802 - A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

January 31, 2031

Study Completion Date

January 31, 2031

Conditions

Friedreich AtaxiaCardiomyopathy

Interventions

GENETIC

ASP2016

Intravenous (IV) infusion

DRUG

Prednisolone

Oral

Trial Locations (5)

University of Florida, Gainesville

Cincinnati Children's Hospital Medical Center, Cincinnati

University of Texas - Houston, Houston

University of California - Los Angeles, Los Angeles

Boston Children's Hospital, Boston